TipRanks
Advertisement
Advertisement

DE:82P Stock Latest News

Pacira price target raised to $31 from $30 at Truist
The FlyPacira price target raised to $31 from $30 at Truist
9h ago
PCRX
Pacira, Molteni Farmaceutici to expand postsurgical pain management access
PremiumThe Fly
Pacira, Molteni Farmaceutici to expand postsurgical pain management access
2d ago
PCRX
Pacira initiated with an Outperform at Oppenheimer
PremiumThe Fly
Pacira initiated with an Outperform at Oppenheimer
15d ago
PCRX
Pacira initiated with a Market Perform at Leerink amid ‘formulary inertia’
PremiumThe Fly
Pacira initiated with a Market Perform at Leerink amid ‘formulary inertia’
28d ago
PCRX
Pacira initiated with a Market Perform at Leerink
PremiumThe Fly
Pacira initiated with a Market Perform at Leerink
29d ago
PCRX
Analyst Initiates Buy on Pacira, Citing Durable Exparel Growth and Pipeline Upside with $30 Price Target
PremiumRatingsAnalyst Initiates Buy on Pacira, Citing Durable Exparel Growth and Pipeline Upside with $30 Price Target
2M ago
PCRX
Pacira reinstated with a Buy at Truist
Premium
The Fly
Pacira reinstated with a Buy at Truist
2M ago
PCRX
Pacira Earnings Call: Growth, Margins and Pipeline
Premium
Company Announcements
Pacira Earnings Call: Growth, Margins and Pipeline
2M ago
PCRX
Pacira price target raised to $25 from $24 at RBC Capital
PremiumThe Fly
Pacira price target raised to $25 from $24 at RBC Capital
2M ago
PCRX
Pacira cuts FY26 revenue view to $735M-$760M from $745M-$770M,
PremiumThe Fly
Pacira cuts FY26 revenue view to $735M-$760M from $745M-$770M,
2M ago
PCRX
Pacira reports Q2 EPS 73c, consensus 65c
PremiumThe Fly
Pacira reports Q2 EPS 73c, consensus 65c
2M ago
PCRX
PCRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PCRX Earnings this Week: How Will it Perform?
2M ago
PCRX
Pacira Therapeutics: PCRX-201 Progress and Key ASCEND Catalysts Support Buy Rating; $32 Price Target Reaffirmed
PremiumRatingsPacira Therapeutics: PCRX-201 Progress and Key ASCEND Catalysts Support Buy Rating; $32 Price Target Reaffirmed
2M ago
PCRX
Pacira transitions PCRX-201 to a U.S.-based manufacturing process
Premium
The Fly
Pacira transitions PCRX-201 to a U.S.-based manufacturing process
2M ago
PCRX
Pacira announces UnitedHealth provides separate reimbursement for Exparel
Premium
The Fly
Pacira announces UnitedHealth provides separate reimbursement for Exparel
3M ago
UNH
PCRX
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
PremiumRatings
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
3M ago
PCRX
Pacira BioSciences Divests CryoTech to Zimmer Biomet
PremiumCompany Announcements
Pacira BioSciences Divests CryoTech to Zimmer Biomet
3M ago
8K
PCRX
Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront
PremiumThe Fly
Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront
3M ago
ZBH
PCRX
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
PremiumCompany Announcements
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
4M ago
8K
PCRX
Glass Lewis recommends shareholders vote for Pacira director nominees
PremiumThe FlyGlass Lewis recommends shareholders vote for Pacira director nominees
4M ago
PCRX
Pacira study shows Exparel reduces opioid use and costs
Premium
The Fly
Pacira study shows Exparel reduces opioid use and costs
4M ago
PCRX
Pacira issues statement on DOMA’s ‘misleading’ statements
Premium
The Fly
Pacira issues statement on DOMA’s ‘misleading’ statements
4M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >